Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Bioxyne Limited
  6. Summary
    BXN   AU000000BXN6

BIOXYNE LIMITED

(BXN)
  Report
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
06/15/2021 06/16/2021 06/17/2021 06/21/2021 06/22/2021 Date
0.026 0.023 0.023 0.023 0.024 Last
187409 1148104 105 940193 199585 Volume
+18.18% -11.54% 0.00% 0.00% +4.35% Change
Estimated financial data (e)
Sales 2019 2,20 M 1,66 M 1,66 M
Net income 2019 -1,27 M -0,96 M -0,96 M
Net cash position 2019 1,77 M 1,34 M 1,34 M
P/E ratio 2019 -9,00x
Yield 2019 -
Sales 2020 2,32 M 1,75 M 1,75 M
Net income 2020 -0,59 M -0,45 M -0,45 M
Net cash position 2020 1,70 M 1,28 M 1,28 M
P/E ratio 2020 -10,8x
Yield 2020 -
Capitalization 15,4 M 11,6 M 11,6 M
EV / Sales 2019 4,43x
EV / Sales 2020 2,02x
Nbr of Employees -
Free-Float 34,4%
More Financials
Company
Bioxyne Limited is an Australia-based bio-technology company engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The Company has an agreement to manufacture, market, supply and distribute its probiotic strain for over the counter dietary supplement products. Its segments include Probiotics and Other. It... 
More about the company
All news about BIOXYNE LIMITED
2017BIOXYNE LTD : RIGHTS ISSUE: 1 new share @ 0.01 AUD for 1 existing share
FA
2014BIOXYNE LTD  : December 2013 Quarterly update and Appendix 4C
PU
2014BIOXYNE LTD  : Amended Appendix 3Y's for Adjustment to Directors Share Interests
PU
2013BIOXYNE LTD  : Expiry of Unquoted Options
PU
2013BIOXYNE LTD  : Sale of HI-164OV Hunter Immunology Pty Ltd
PU
2013BIOXYNE LTD  : Appendix 4C - September Quarterly
PU
2013BIOXYNE LTD  : Confirmation of Release - BXN - Termination of proposed acquisiti..
PU
2013BIOXYNE LTD  : Confirmation of Release - BXN - Appendix 4C - quarterly - 31 Marc..
PU
2013BIOXYNE LTD  : Confirmation of Release - BXN - Vitality Devices Acquisition Upda..
PU
2013BIOXYNE LTD  : Confirmation of Release - BXN - Completion of placement follow up
PU
2013BIOXYNE LTD  : Confirmation of Release - BXN - Suspension Request
PU
2013BIOXYNE LTD  : Bioxyne Appoints New CFO and Change of Registered Office
PU
2013BIOXYNE LTD  : Confirmation of Release - BXN - Completion of Placement
PU
2013BIOXYNE LTD  : Confirmation of Release - BXN - Status Review HI 164OV Further Up..
PU
2013BIOXYNE LTD  : Confirmation of Release - BXN - Proposed Acquisition of Vitality
PU
More news
News in other languages on BIOXYNE LIMITED

- No features available -

More news
Chart BIOXYNE LIMITED
Duration : Period :
Bioxyne Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Nam-Hoat Chua Chief Executive Officer, MD & Director
Guy Robertson Chief Financial Officer & Secretary
Peng Ho Non-Executive Chairman
Patrick Douglas Ford Non-Executive Director
Peter Charles Hughes-Hallett Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOXYNE LIMITED91.67%11
MODERNA, INC.99.33%83 614
LONZA GROUP AG13.26%52 103
IQVIA HOLDINGS INC.35.88%46 660
CELLTRION, INC.-24.79%33 793
SEAGEN INC.-9.62%28 728